Magnetic resonance imaging, Nuclear medicine, Radiology, Pathology and Medical physics are his primary areas of study. His research on Magnetic resonance imaging focuses in particular on Dynamic contrast-enhanced MRI. His Nuclear medicine research includes themes of Pelvic cavity and Pelvis.
His work in the fields of Radiology, such as Diffusion MRI, Positron emission tomography and Real-time MRI, overlaps with other areas such as Image registration. His Pathology study incorporates themes from Prostate cancer and Oncology. His Medical physics research is multidisciplinary, incorporating perspectives in Cancer therapy, Clinical trial and Angiography.
Anwar R. Padhani mostly deals with Magnetic resonance imaging, Radiology, Prostate cancer, Internal medicine and Cancer. His Magnetic resonance imaging research is multidisciplinary, relying on both Nuclear medicine, Pathology, Medical physics, Breast cancer and Radiation therapy. His Pathology research also works with subjects such as
The study of Radiology is intertwined with the study of Prospective cohort study in a number of ways. His research integrates issues of Prostate and Disease in his study of Prostate cancer. While the research belongs to areas of Internal medicine, Anwar R. Padhani spends his time largely on the problem of Oncology, intersecting his research to questions surrounding Primary breast cancer.
His primary areas of investigation include Prostate cancer, Radiology, Magnetic resonance imaging, Medical physics and Prostate. Anwar R. Padhani has included themes like Biopsy, Disease and Oncology in his Prostate cancer study. The concepts of his Oncology study are interwoven with issues in Breast cancer, Metastatic breast cancer and Prostate cancer screening.
His study explores the link between Radiology and topics such as Metastasis that cross with problems in Adverse effect and Randomized controlled trial. His Magnetic resonance imaging research is mostly focused on the topic Whole body imaging. In Medical physics, Anwar R. Padhani works on issues like Positron emission tomography, which are connected to Cancer staging.
Anwar R. Padhani mainly focuses on Prostate cancer, Magnetic resonance imaging, Medical physics, Prostate and Cancer. His Prostate cancer research incorporates themes from Guideline, Disease and Oncology. His study in Oncology is interdisciplinary in nature, drawing from both Clinical trial, Hormone sensitive prostate cancer and Consensus conference.
His study on Magnetic resonance imaging is covered under Radiology. Anwar R. Padhani has researched Medical physics in several fields, including Whole body imaging, Positron emission tomography and Systematic review. His Colorectal cancer, Adverse effect and Metastasis study, which is part of a larger body of work in Internal medicine, is frequently linked to Pregnancy, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Anwar R. Padhani;Guoying Liu;Dow Mu-Koh;Thomas L. Chenevert.
Neoplasia (2009)
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach;C R M Boggis;A K Dixon;D F Easton.
The Lancet (2005)
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
Louise Dickinson;Louise Dickinson;Louise Dickinson;Hashim U. Ahmed;Hashim U. Ahmed;Clare Allen;Jelle O. Barentsz.
European Urology (2011)
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
Jeffrey M. Arbeit;J. Martin Brown;K. S.Clifford Chao;J. Donald Chapman.
International Journal of Radiation Biology (2006)
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
Martin O Leach;K Brindle;J Evelhoch;John R Griffiths.
British Journal of Cancer (2005)
Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions
Anwar R. Padhani.
Journal of Magnetic Resonance Imaging (2002)
Diffusion MRI for prediction of response of rectal cancer to chemoradiation
Andrzej Dzik-Jurasz;Claudia Domenig;Mark George;Jan Wolber.
The Lancet (2002)
Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use
Jelle O. Barentsz;Jeffrey C. Weinreb;Sadhna Verma;Harriet C. Thoeny.
European Urology (2016)
Imaging biomarker roadmap for cancer studies.
James P.B. O'Connor;Eric O. Aboagye;Judith E. Adams;Hugo J.W.L. Aerts;Hugo J.W.L. Aerts.
Nature Reviews Clinical Oncology (2017)
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.
Baris Turkbey;Andrew B. Rosenkrantz;Masoom A. Haider;Anwar R. Padhani.
European Urology (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Royal Marsden NHS Foundation Trust
Radboud University Nijmegen
Northwood University
Imperial College Healthcare NHS Trust
University of Oxford
Mount Vernon Hospital
National Institutes of Health
Royal Marsden NHS Foundation Trust
University of Bologna
Institute of Cancer Research
Georgia Institute of Technology
University of Zaragoza
University of Sannio
Commonwealth Scientific and Industrial Research Organisation
University of California, Berkeley
Oregon State University
Wake Forest University
University of Hawaii at Manoa
Pusan National University
National Institutes of Health
University of California, Irvine
Deakin University
Cardiff University
University of Edinburgh
University of Sydney
Rutgers, The State University of New Jersey